Despite the detection of elevated levels of O‐GlcNAcylation in various cancer types, our study presents novel evidence demonstrating the physiological O‐GlcNAcylation of NRF2, which is implicated in tumour malignancy and cisplatin resistance. This evidence concerns the gene NFE2L2 and neoplasm.